OpenArc Corporate Advisory’s Zimmer Biomet ZBH Stock Holding History

OpenArc Corporate Advisory’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$246K	Buy	2,717 +323	+13%	+$29.6K	﹤0.01%	618
2025 Q4	$215K	Buy	+2,394	New	+$227K	﹤0.01%	596

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OpenArc Corporate Advisory's ZBH Position: Q1 2026 in Review

OpenArc Corporate Advisory increased its Zimmer Biomet (ZBH) stake by 13% in Q1 2026, buying an estimated $29.6K and bringing the position to 2,717 shares worth $246K. The position accounts for ﹤0.01% of the portfolio, ranked #618.

OpenArc Corporate Advisory first reported a position in ZBH in Q4 2025 and has held it in 2 quarters since. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

OpenArc Corporate Advisory held 2,717 shares of Zimmer Biomet worth $246K as of Q1 2026.
OpenArc Corporate Advisory bought 323 Zimmer Biomet shares in Q1 2026, an estimated $29.6K.
Zimmer Biomet made up ﹤0.01% of OpenArc Corporate Advisory's portfolio in Q1 2026, its #618 holding.
OpenArc Corporate Advisory first reported a position in Zimmer Biomet in Q4 2025 and has held it in 2 quarters since.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on OpenArc Corporate Advisory's 13F filing for Q1 2026, filed 11 May 2026.